Literature DB >> 27570780

Colonic Spirochetosis in a 60-Year-Old Immunocompetent Patient: Case Report and Review.

Taiwo Ngwa1, Jennifer L Peng1, Euna Choi2, Sucharat Tayarachakul1, Suthat Liangpunsakul3.   

Abstract

Spirochetes, a genetically and morphologically distinct group of bacteria, are thin, spiral-shaped, and highly motile. They are known causes of several human diseases such as syphilis, Lyme disease, relapsing fever, and leptospirosis. We report a case of colonic spirochetosis in a healthy patient presenting for surveillance colonoscopy. The diagnosis of intestinal spirochetosis was made accidentally during the histological examination of colonic polyps, which were removed during colonoscopy. We also performed an extensive review on intestinal spirochetosis with a focus on clinical presentation and outcomes of reported cases from the past two decades.

Entities:  

Keywords:  Colon; Immunocompetent host; Spirochetosis

Year:  2016        PMID: 27570780      PMCID: PMC4984321          DOI: 10.1177/2324709616662671

Source DB:  PubMed          Journal:  J Investig Med High Impact Case Rep        ISSN: 2324-7096


Introduction

Spirochetes are a genetically and morphologically distinct group of bacteria. Morphologically, they are thin, spiral-shaped, and highly motile.[1] Spirochetes are known causes of several human diseases such as syphilis, Lyme disease, relapsing fever, and leptospirosis. Intestinal infestation by spirochetes has long been recognized.[2] Clinical presentations vary, ranging from asymptomatic to gastrointestinal (GI)-related symptoms such as bleeding or diarrhea.[3] We report a case of colonic spirochetosis in a healthy patient who initially presented for surveillance colonoscopy. Additionally, we also perform an extensive review of previously reported cases in the literature.

Case Report

A 60-year-old asymptomatic man with no significant past medical history underwent a surveillance colonoscopy due to a previous history of a 1.8-cm hyperplastic polyp at the ileocecal valve. He denied weight loss and any GI symptoms, such as abdominal pain, diarrhea, or rectal bleeding. Colonoscopy revealed 2 tubular adenoma polyps in the cecum and 6 hyperplastic polyps in the rectosigmoid junction, ranging from 2 to 4 mm. The hematoxylin and eosin (H&E) stain of these polyps showed several filamentous structures on the colonic epithelium (Figures 1 and 2). A Warthin-Starry stain was subsequently performed and confirmed the diagnosis of intestinal spirochetosis (Figure 3). He also tested negative for HIV (human immunodeficiency virus) infection.
Figure 1.

Intestinal spirochetosis on H&E stain (20×). Solid black arrow indicates spirochetes attached to the luminal side of colonic mucosa forming a “false brush border.”

Figure 2.

Intestinal spirochetosis on H&E stain (40×). Solid black arrow indicates spirochetes attached to the luminal side of colonic mucosa forming a “false brush border.”

Figure 3.

Intestinal spirochetosis on Warthin-Starry (silver) stain (40×). Solid black arrow indicates spirochetes attached to the luminal side of colonic mucosa forming a “false brush border.”

Intestinal spirochetosis on H&E stain (20×). Solid black arrow indicates spirochetes attached to the luminal side of colonic mucosa forming a “false brush border.” Intestinal spirochetosis on H&E stain (40×). Solid black arrow indicates spirochetes attached to the luminal side of colonic mucosa forming a “false brush border.” Intestinal spirochetosis on Warthin-Starry (silver) stain (40×). Solid black arrow indicates spirochetes attached to the luminal side of colonic mucosa forming a “false brush border.”

Discussion

Intestinal spirochetosis (IS), first described by Harland and Lee in 1967 using electron microscopy,[4,5] is an uncommon disease in humans defined by colonization of the luminal surface of colonic epithelial cells with anaerobic spirochetes of the Brachyspiraceace family, which include Brachyspira aalborgi (measuring 2-6 µm in length) and Brachyspira piloscoli (measuring 4-20 µm in length).[6,7] The prevalence of IS varies from 2.5% to 32%, depending on geographic locations and diagnostic modalities.[6,8,9] The reported prevalence of human IS found in rectal biopsy specimens ranges between 2% and 7% in Western countries, whereas the prevalence is considerably higher in patients from India and other parts of Asia.[6] Of note, the overall prevalence is much lower when the diagnosis is made using stool culture (1.2% to 1.5%[6,10]) compared to that from mucosal biopsies. The highest prevalence of IS was previously reported in homosexual men (30% to 60%) as well as in HIV-positive patients.[3,6,7,11] However, in a recent study from Japan including 5265 consecutive colorectal biopsies from 4254 patients, the authors found that 5.5% of those with HIV seropositivity had IS compared to 1.7% in those with negative serology.[7] The lengths of the spirochetes were also significantly longer in HIV-positive patients.[7] IS is found primarily in the colon, though there have been reported cases in the stomach and small intestine from the early 1900s.[6] Similar to the case we present, most cases of IS are an incidental finding discovered during a screening/surveillance colonoscopy.[5] The clinical as well as prognostic significance of IS are debatable. Given the lack of association between the presence of IS and GI symptoms, current theory suggests IS has a commensal relationship with the human host and is part of normal flora.[2,6,12] However, spirochetes can become pathogenic and invasive in a subset of patients, due to diminishing host defenses or a pathologic factor favoring the virulence of the microorganism.[6] In symptomatic cases, IS most commonly presents with chronic watery diarrhea and abdominal pain. Most cases are mild. However, some may present with an invasive and rapidly fatal course.[6] Using PubMed, we searched the English-language literature published between January 1996 and May 2016. The terms utilized in the search were “intestinal spirochetosis” and “human subjects.” Reference lists of the identified articles were also reviewed to find additional cases. The baseline characteristics, clinical presentations, as well as outcomes of these cases are presented in Table 1.
Table 1.

Clinical Characteristics of Reported Cases With IS From 1996 to 2016[a].

Year (Reference)Age (Years)/SexUnderlying Condition/Risk FactorClinical PresentationEndoscopic FindingsHistologic FindingsTreatmentOutcome
Adult population (18 years of age and older)
 2015[17]39/maleHIVWatery, nonbloody diarrhea, abdominal distentionNormalISPenicillin (2 weeks)Initially, responded well but then developed toxic megacolon 2 years later requiring total colectomy
 2015[18]63/maleHealthyAsymptomatic, + FOBTIntestinal stricture of transverse colonChronic infective colitis consistent with ISMetronidazole (2 weeks)Not effective, pathology showed mucinous adenocarcinoma associated with IS requiring subtotal colectomy
 2014[19]37/male15-year history of pan-ulcerative total colitisDiarrhea 2-3 times per day, occasional bloody stoolsMild erosive mucosa in both sigmoid colon and rectum; longitudinal ulcer in transverse colonISMesalazine + prednisoloneResponsive to mesalazine and prednisolone but difficult to taper prednisolone; improvement after metronidazole
Metronidazole
61/male20-year history of distal ulcerative colitisDiarrhea 4-5 times per day, occasional bloody stoolsIrregularly shaped ulcer in rectumISPrednisoloneNo resolution of ulcer with prednisolone; improvement with metronidazole
Metronidazole
 2014[20]60/maleHepatitis C cirrhosisProgressive weight lossSessile polyp in ascending colonISNo treatmentNo follow-up information
 2011[21]34/maleHealthyAbdominal pain, diarrheaNot performed; CT showed colocolic intussusceptionIS; florid lymphoid hyperplasia in submucosa of terminal ileum and ileocecal valveRight hemicolectomyResolution
 2010[22]60/maleHealthyLower abdominal pain, loose stoolsMild erythema of cecum and ascending colonISMetronidazole (400 mg ×10 days)Improvement
 2009[23]Middle-agedHIVSoft stools, occasionally bloodySmall polyp in cecumTubular adenoma with IS on luminal epitheliumAmoxicillinNo follow-up information
 2008[24]23/maleHealthyDiarrheaPatchy edema with areas of erythema and small erosionsPatchy mucosal inflammation and ISClarithromycin (800 mg/day ×10 days)Improvement
 2010[25]68/maleHealthyPersistent diarrheaNormalISMetronidazole (750 mg/8 h ×10 days)Resolution
 2007[26]17 cases in the series/age 4-75Healthy and those with HIVDiarrhea, abdominal discomfort, abdominal pain, iron deficiency anemiaAll cases with mucosal erosions/hyperemiaInflammatory cells infiltrateMetronidazoleResolution except for one died from pulmonary embolism and one lost to follow-up
 2007[27]31/maleHealthyAbdominal pain, watery diarrheaEdematous mucosa with erythematous spots in ascending and transverse colon; sigmoid sessile polypISMetronidazole (1000 mg/day ×7 days)Resolution
 2006[28]11 cases in the series/age 29-87Healthy and those with HIVDiarrhea and abdominal painNormal to extensive area of inflammationNormal mucosa to inflammatory cells infiltrate and mucosal ulcerationMetronidazole (500 mg PO 4 times per day)Resolution except 2 with persistent diarrhea, and one subject with abdominal pain but without reported outcome
Some cases received benzathine penicillin 2.4 million units IM single dose
 2005[29]62/maleHIVFlatulence, intestinal hemorrhagePan-colonic hypotonic diverticular diseaseISPenicillin GResolution
 2004[30]41/maleHIV, neuropathy, GERD, depressionAbdominal pain, loose stools, hematocheziaNonspecific inflammation without colitisISMetronidazoleResolution
 2004[31]57/femaleRectal prolapseAsymptomaticNot performedIS and pneumatosis coli; IS within pneumatic cystsNo information on treatmentNo follow-up
 2002[32]78/maleNon-Hodgkin lymphomaSevere bloody diarrhea, abdominal painNot performedISNo information on treatmentNo follow-up
 2001[33]50/maleHealthyDiarrhea, abdominal crampingNormalISMetronidazoleResolution
 2000[34]57/maleHealthyAsymptomaticTwo polyps in descending and sigmoid colonISNo information on treatmentNo follow-up
 2000[35]32/maleHealthyBloating, lower abdominal pain, watery diarrheaNormalISMetronidazole (500 mg 4×/day for 10 days)Improvement
 1998[36]65/malePresumed healthy (HIV test not performed)Weight lossRed spot on mucosa of cecum, small polyps in descending colonISNo treatmentNo follow-up
 1996[37]21/femaleHealthy; heterosexualRectal bleedingActive proctitis, mild erythema of rectal and colonic mucosaISHydrocortisone 1% rectal foamResolution
28/maleHealthy; heterosexualIntermittent nausea and lassitude, weight lossPatchy erythema in sigmoid colon, intense erythema, mucosal nodularity and friability in distal rectumIS in rectal biopsy; lymphocytes and plasma cells within lamina propria, no spirochetes on sigmoid biopsyHigh fiber diet (unsure etiology of symptoms and thought to have post-infectious IBS)Improvement
45/maleHealthy; heterosexualColicky pain in left iliac fossa, flatulence, diarrheaNormalISNo treatment (diagnosed with IBS due to uncertain significance of intestinal spirochetosis at that time)No follow-up
Pediatric population (0-18 years of age)
 2012[38]13/maleRecurrent aphthous stomatitisBlood-stained diarrhea, urgency, weight lossMucosal edema in sigmoid and rectumISAmoxicillin (2 weeks)Cessation of rectal bleeding but continuous mucous diarrhea with amoxicillin; resolution with metronidazole
Metronidazole (10 days)
 2012[39]14/femaleHealthyIntermittent generalized abdominal painNormalISMetronidazoleNo follow-up
 2010[40]11/femaleHSV, psoriasis, upper airway diseaseIntermittent abdominal pain, hematocheziaNormalISMetronidazole (250 mg 3×/day)No improvement after repeated courses of metronidazole and vancomycin, spirochetes found on repeat endoscopy
Metronidazole (1000 mg for 2 weeks, 2 months, then 750 mg/day for 2 weeks)No follow-up information
Vancomycin (7 days)
6/maleHealthyStomach cramps, hematochezia, intermittent diarrhea, rectal prolapse, “pencil-thin” stoolsNormalISMetronidazole (250 mg 3×/day for 2 weeks)Mild improvement but continuous alternating constipation with watery diarrhea, continuous regurgitation, rectal prolapse
11/femaleHealthyRight lower quadrant painNot performedMild acute appendicitis and IS in resected appendixCefoxitin (30 mg/kg/dose × 4 doses)Resolution
Appendectomy
17/femaleHealthyRelapsing abdominal pain, nausea, vomitingPerformed, no informationMild eosinophilic inflammatory infiltrate with ISNo treatmentNo follow-up
10/maleHealthyPeriumbilical and epigastric pain, nausea, feverNot performedAcute appendicitis and IS in resected appendixNo treatmentNo follow-up
 2005[41]9/maleHealthyBlood mixed in stool, diarrheaNormalISNo therapyResolution, spirochetes eradicated
 2004[42]9/maleHealthyAbdominal pain, diarrhea, hematocheziaMild erythema of rectal mucosaISErythromycin (40 mg/kg/day × 10 days)Resolution
 2002[43]5/femaleEnterobiasisDiarrhea, abdominal pain, occasional bloodEdema in rectumISErythromycin 40 mg/kg/day × 10 daysRectal bleeding ceased, recurrent abdominal pain; no follow-up
7/maleHealthyAbdominal pain, diarrheaSlight proctitisISDoxycycline (200 mg for 1 day, then 100 mg/day for 8 days)Persistent abdominal symptoms, eradication of spirochetes
4/femaleHealthyMucus and bloody stoolsProctitis, juvenile polypsISClarithromycin (50 mg/kg/day × 10 days)Improvement
10/femaleHealthyBlood-stained diarrheaHyperemic membranes on rectoscopyISClarithromycinResolution
13/maleHealthyAbdominal pain, nausea, weight loss, blood-stained stoolsSlight inflammation of rectumIS and HP-positive gastritisOmeprazoleNo improvement
Clarithromycin, amoxicillin, omeprazoleImprovement with relapse
Clarithromycin, metronidazole, omeprazoleSustained improvement
8/maleHealthyAbdominal painJuvenile polypISPenicillin VNo improvement
Erythromycin (40-50 mg/kg/day × 10 days)Resolution
15/femaleHealthyAbdominal pain, blood-stained stoolsNormalISClarithromycin 500 mg, BID for 2 weeksRelieved discomfort,bleeding persisted; spirochetes eradicated
14/femaleHealthyAbdominal painNormal colonoscopy, HP-positive gastritisISRanitidine + amoxicillinNo improvement
MetronidazoleNo improvement of symptoms, IS eradicated
 2001[44]12/maleHealthyVomiting, diarrhea, weight lossNormalIS with mild focal colitisMetronidazole and amoxicillin for 1 weekResolution
12/maleHealthyAbdominal painNormalISPenicillin V and metronidazole (1 week)Symptoms persisted
Metronidazole (800 mg 3×/day for 1 week)Improvement
16/femaleHealthyRight upper quadrant painNormalISMetronidazole (10 days)Resolution
9.5/femaleHealthyDiarrhea, bright rectal bleedingNormalISAmoxicillin and metronidazole (10 days)Resolution

Abbreviations: IS, intestinal spirochetosis; FOBT, fecal occult blood test; CT, computed tomography; PO, per os; IM, intramuscular; GERD, gastroesophageal reflux disease; IBS, irritable bowel syndrome; HSV, herpes simplex virus; BID, twice a day.

Cases were limited to nonsyphilitic spirochetosis.

Clinical Characteristics of Reported Cases With IS From 1996 to 2016[a]. Abbreviations: IS, intestinal spirochetosis; FOBT, fecal occult blood test; CT, computed tomography; PO, per os; IM, intramuscular; GERD, gastroesophageal reflux disease; IBS, irritable bowel syndrome; HSV, herpes simplex virus; BID, twice a day. Cases were limited to nonsyphilitic spirochetosis. One crucial observation in our case is that the presence of colonic spirochetosis is found on mucosa adjacent to colonic polyps. This leads to the question of whether there is any association between IS and colonic polyps. Omori et al conducted a retrospective case-control study to determine the prevalence of IS in sessile serrated adenomas/polyps (SSA/Ps) in 19 SSA/P cases and 172 controls.[13] They found that the rate of IS was significantly higher in the SSA/P cases (52.6%, 10/19 cases) compared to that in controls (8.1%, 14/172), suggesting the potential association between IS and SSA/Ps. The finding from this study is similar to results from an Italian study in which the authors also proposed an association between IS and hyperplastic/adenomatous colonic polyps.[14] Further studies are needed to determine the implications of IS and the presence of colonic polyps. The endoscopic examination of colonic mucosa has limited value in making diagnosis of IS. In a study of 15 cases with biopsy-proven IS, colonoscopic findings were normal in 6 subjects and nonspecific in the remaining cases (7 with polypoid lesions, 1 with erythematous mucosa, and 1 with questionable lesion).[15] In general, IS cannot be detected with routine colonoscopy. However, a recent study showed the potential of in vivo diagnosis of IS using confocal endomicroscopy with fluorescein sodium as a contrasting agent and Acriflavine hydrochloride,as a topical agent to highlight superficial cell borders and nuclei.[16] Using this technique, the spirochetes become visible as bright ring-like bands within the lumina of the crypts.[16] Of note, in clinical practice, IS is normally found coincidentally in biopsies taken from areas of intestinal mucosa with an irregular appearance. However, in the majority of cases, it is discovered during random biopsies of normal appearing colonic mucosa.[5] The histological apperances of IS on biopsy specimens using H&E stain is a diffuse blue fringe, approximately 3 to 6 µm thick, along the border of the intercryptal epithelial layer (Figures 1 and 2).[5] The presence of spirochetes can be confirmed with Warthin-Starry stain (Figure 3). The decision on whether to treat IS should be tailored to the clinical presentation, the severity of the patients’ symptoms, and their immune status.[5,6,11] IS can either present asymptomatically, as the organisms responsible are thought to have a commensal relationship with normal gut flora, or symptomatically with associated GI symptoms, as the organisms can also have an invasive, pathogenic form (Table 1). For the former presentation and in a patient such as the one we present, a “wait-and-see” observational approach without any interventions is appropriate. For symptomatic patients, medical treatment with metronidazole (500 mg 4 times a day for 10 days) has been shown to be beneficial.[5,6] In conclusion, IS can be found accidentally from colonic biopsies, and, in most cases, there is no correlation with clinical symptoms. The association of IS and the presence of colonic polyps has been reported, though further investigation is required to confirm these anecdotal findings. Most cases can be followed without specific treatment. For symptomatic cases, metronidazole is an effective treatment of choice.
  44 in total

1.  Pathologic quiz case. Colon biopsy in a patient with diarrhea--Possible etiologic agent.

Authors:  R N Shah; V Stosor; S Badve
Journal:  Arch Pathol Lab Med       Date:  2001-05       Impact factor: 5.534

2.  Spirochaetes can colonize colorectal adenomatous epithelium.

Authors:  A A Palejwala; R Evans; F Campbell
Journal:  Histopathology       Date:  2000-09       Impact factor: 5.087

3.  Spirochaetes within the cysts of pneumatosis coli.

Authors:  M Körner; J-O Gebbers
Journal:  Histopathology       Date:  2004-08       Impact factor: 5.087

4.  Spirochetosis resulting in fulminant colitis.

Authors:  Michael Honaker; Beverly Lauren Paton; Michal Kamionek; Lynn Schiffern
Journal:  Surgery       Date:  2014-10-14       Impact factor: 3.982

Review 5.  Intestinal spirochetosis in children: five new cases and a 20-year review of the literature.

Authors:  David F Carpentieri; Stephanie Souza-Morones; Jennifer S Gardetto; Hillary M Ross; Katherine Downey; Kristy Ingebo; Emmanuel Siaw
Journal:  Pediatr Dev Pathol       Date:  2010-03-23

6.  Education and Imaging. Gastrointestinal: colonic spirochetosis.

Authors:  K Tsuzawa; N Fujisawa; Y Sekino; K Suzuki; K Saito; S Koyama; M Tanaka; A Wada; M Inamori; K Kubota; A Nakajima
Journal:  J Gastroenterol Hepatol       Date:  2008-07       Impact factor: 4.029

7.  Intestinal spirochetosis and chronic watery diarrhea: clinical and histological response to treatment and long-term follow up.

Authors:  Maria Esteve; Antonio Salas; Fernando Fernández-Bañares; Josep Lloreta; Meritxell Mariné; Clara Isabel Gonzalez; Montserrat Forné; Jaume Casalots; Rebeca Santaolalla; Jorge Carlos Espinós; Mohammed Arif Munshi; David John Hampson; Josep Maria Viver
Journal:  J Gastroenterol Hepatol       Date:  2006-08       Impact factor: 4.029

8.  The first reported case of intestinal spirochaetosis in Japan.

Authors:  S Nakamura; T Kuroda; T Sugai; S Ono; T Yoshida; I Akasaka; F Nakashima; S Sasou
Journal:  Pathol Int       Date:  1998-01       Impact factor: 2.534

9.  Intestinal spirochetosis due to Brachyspira pilosicoli: endoscopic and radiographic features.

Authors:  Junji Umeno; Takayuki Matsumoto; Shotaro Nakamura; Sohei Yoshino; Minako Hirahashi; Takashi Yao; Mitsuo Iida
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

Review 10.  Human intestinal spirochetosis--a review.

Authors:  Efstathia Tsinganou; Jan-Olaf Gebbers
Journal:  Ger Med Sci       Date:  2010-01-07
View more
  2 in total

Review 1.  The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans.

Authors:  David J Hampson
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

2.  Intestinal Spirochetosis in an Immunocompetent Patient.

Authors:  Patricia Guzman Rojas; Jelena Catania; Jignesh Parikh; Tran C Phung; Glenn Speth
Journal:  Cureus       Date:  2018-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.